The APIS team will be exhibiting and speaking at the Antibody Engineering & Therapeutics Europe conference at the Postillion Hotel, Amsterdam.

Come and meet us at stand 21.

APIS’ deep expertise and capabilities in platform agnostic IVD development of molecular & immunoassays for ultimate product realisation as diagnostic tests.

Innovative synthetic ‘Clickmer’ high-affinity ligand binding technology, for the validation and translation of biomarker and drug assets into clinical utility.

The APIS SARS-CoV-2 IgG ELONA Kit is intended for the quantitative detection of IgG antibodies to SARS-CoV-2 spike protein in human serum and utilises Clickmers. The results of this assay will aid in clinical decision making, vaccine development and booster dosing, and clinical research studies.

Interested in learning more? Use this link to contact us and schedule a meeting.